Latest MiMedx Group Inc. Stories
MARIETTA, Ga., May 9, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTC BB: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it will present at the Noble Financial Capital Markets' Seventh Annual Equity Conference at the Hard Rock Hotel in Hollywood, Florida. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, Michael J. Senken, Chief Financial Officer and John Daniel, President of Surgical...
MARIETTA, Ga., May 4, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants processed from human amniotic membrane, announced today the launch of AmnioFix(TM) Nerve Wrap, the Company's latest biologic implant processed to offer surgical and healing options for nerve repair. Produced from the MiMedx Group's proprietary Purion® process, AmnioFix(TM) Nerve Wrap is an allograft...
MARIETTA, Ga., April 26, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants processed from human amniotic membrane, announced today its results for the three months ended March 31, 2011. Revenue for the three months ended March 31, 2011, was approximately $1,044,000, as compared to revenue of $114,900 recorded for the three months ended March 31, 2010. The Company recorded...
MARIETTA, Ga., April 21, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today the Company's attendance at the upcoming International Society for the Advancement of Spine Surgery Annual Meeting, April 26 - 29, 2011. The meeting will be held at the Venetian Congress Center, located within the Venetian / Palazzo Hotels in Las Vegas, Nevada. MiMedx will highlight two...
MARIETTA, Ga., April 19, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that its results for the first quarter, ended March 31, 2011, will be released before the opening of the market on Tuesday, April 26, 2011. MiMedx will host a live broadcast of its first quarter conference call on April 26, 2011, beginning at 10:30 a.m. Eastern Time. A listen-only simulcast of...
MARIETTA, Ga., April 11, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants processed from human amniotic membrane, announced today the nation-wide launch of the Company's latest product, EpiFix(TM), a biologic implant specifically processed to offer a wide variety of wound healing and wound care options. The Company also announces the hiring of Frank Burrows as its Vice...
MARIETTA, Ga., March 28, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants processed from human amniotic membrane, announced today its results for the year ended December 31, 2010. Full Year 2010 Results In 2010, the Company changed its fiscal year to coincide with the calendar year. Its prior fiscal year was from April 1st through March 31st. Therefore,...
MARIETTA, Ga., March 16, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it will present at the 10th Annual Needham Healthcare Conference in New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO of MiMedx, and John Daniel, President of Surgical Biologics, a wholly-owned subsidiary of MiMedx, are scheduled to present...
MARIETTA, Ga., Feb. 23, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that its results for the fourth quarter and full year ended December 31, 2010, and Company guidance will be released after the closing of the market on Monday, March 28, 2011. The timing of the earnings announcement allows MiMedx time to finalize the required two year audit of its...
SAN DIEGO, Feb. 16, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced the launch of AmnioFix(TM), the Company's newest technology platform. MiMedx formally unveiled AmnioFix(TM) earlier today during the first day of the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting being held in San Diego, California. MiMedx recently acquired its AmnioFix(TM)...
